Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
68,958,635
-
Number of holders
-
129
-
Total 13F shares, excl. options
-
58,658,581
-
Shares change
-
+913,984
-
Total reported value, excl. options
-
$700,332,942
-
Value change
-
+$12,555,131
-
Put/Call ratio
-
16%
-
Number of buys
-
65
-
Number of sells
-
58
-
Price
-
$11.94
Institutional Holders of Olema Pharmaceuticals, Inc. - Common Stock (OLMA) as of Q3 2024
As of 30 Sep 2024 Olema Pharmaceuticals, Inc. - Common Stock (OLMA) had 129 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 58,658,581 shares of stock of the company.
Largest 10 holders included BVF INC/IL, Paradigm Biocapital Advisors LP, Deep Track Capital, LP, BlackRock, Inc., Point72 Asset Management, L.P., Logos Global Management LP, MPM BIOIMPACT LLC, VANGUARD GROUP INC, STATE STREET CORP, and Pictet Asset Management Holding SA.
This table shows 129 institutional shareholders of the security as of 30 Sep 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.